Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Consulting agrmnt
SPECTRANETICS CORP (SPNC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2017 GN Spectranetics Announces Fundamental Change, Make-Whole Adjustment Event, Share Exchange Event and Supplemental Indenture for 2.625% Convertible Senior Notes due 2034
08/03/2017 GN Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
07/26/2017 GN Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon
07/13/2017 GN Spectranetics Announces Second Quarter Earnings Release Date
06/28/2017 GN Philips to acquire The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac and peripheral vascular disease
06/09/2017 GN Spectranetics Announces $140 Million Debt Refinancing
05/11/2017 GN Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors
05/11/2017 GN Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors
04/07/2017 GN Spectranetics Announces First Quarter 2017 Conference Call
02/23/2017 GN Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
02/02/2017 GN Spectranetics Announces Fourth Quarter 2016 Conference Call
10/08/2012 GN Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels
08/23/2012 GN Spectranetics to Participate in Upcoming Investor Conferences
07/26/2012 GN Spectranetics Achieves Second Quarter Revenue of $35.0 Million
07/18/2012 GN Spectranetics to Hold 2012 Second Quarter Financial Results Conference Call on July 26

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy